相关实验视频

Updated: Jul 23, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

针对MYC驱动的淋巴瘤:经验教训和未来的方向

Sandra Martínez-Martín¹, Marie-Eve Beaulieu¹, Laura Soucek^1,2,3

¹Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.

Cancer drug resistance (Alhambra, Calif.)

|July 17, 2023

概括

在侵袭性B细胞淋巴瘤中,MYC至关重要,推动瘤生长. 针对MYC的疗法是有希望的,但MYC过度表达淋巴瘤的敏感性需要进一步调查.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

MYC瘤基因是瘤发生的关键驱动因素,调节细胞增殖,生长和存活.
MYC过度表达与淋巴发育有很大关系,特别是在攻击性的B细胞淋巴瘤中,如高度B细胞淋巴瘤 (HGBL) 和双表达扩散的大B细胞淋巴瘤 (DLBCL).
这些MYC成的淋巴瘤在理论上对MYC退出敏感,使MYC向治疗成为一个重要的研究领域.

研究的目的:

审查目前针对MYC瘤基因的治疗策略,以对抗侵袭性B细胞淋巴瘤.
评估高MYC水平对MYC向疗法的敏感性的预测值.
讨论针对MYC驱动的攻击性B细胞淋巴瘤的新药开发方法,包括MYC/BCL2或BCL6变异的B细胞淋巴瘤.

主要方法:

对MYC向性治疗在侵袭性B细胞淋巴瘤中的临床前和临床研究的文献综述.
分析MYC在淋巴发育和治疗抵抗机制中的作用.
新兴的MYC向药物类别及其作用机制的分类.

主要成果:

MYC过度表达是攻击性B细胞淋巴瘤的标志,使人对MYC活动产生上.
虽然MYC戒断是治疗目标,但高MYC水平和对向疗法的敏感性之间的直接相关性尚未完全确立.
目前正在开发几类间接准MYC的分子,在临床前模型中显示出有前途的结果.

结论:

准MYC是对攻击性B细胞淋巴瘤的关键策略,特别是那些MYC/BCL2或BCL6转位/过度表达的淋巴瘤.
需要进一步的研究来澄清敏感性预测因子,并优化治疗方法.
开发新的MYC抑制剂或间接向策略具有显著的治疗潜力.

关键词:

高度B细胞淋巴瘤高度B细胞淋巴瘤我的世界 MYC 在MYC治疗中,MYC疗法.双表达体淋巴瘤是双表达体淋巴瘤.

更多相关视频

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...